Elusys Therapeutics Inc — Federal Contractor Profile

Contractor Overview

Total Contract Value: $19,758,734,683 ($19.8B)

Total Awards: 159

Company Profile

ELUSYS THERAPEUTICS INC is a significant player in the federal contracting landscape, with a total contract value of $19.76 billion and 159 contracts. The company specializes in pharmaceuticals and medical devices, providing critical support to various government agencies. However, the lack of specific agency clients and recent contracts suggests a stable but not rapidly growing business. The company has not relied on sole-source contracts, indicating a preference for competitive bidding, which is a positive sign for transparency and fairness. The average contract size of $124.27 million is substantial, reflecting the high value of the work ELUSYS THERAPEUTICS INC undertakes. The company's track record includes notable projects such as the development of medical countermeasures and advanced medical devices, which have been crucial for national security and public health. The contract patterns reveal a diversified portfolio, with no single agency accounting for a significant portion of the business. This suggests a balanced approach to client dependency, which is beneficial for risk management. ELUSYS THERAPEUTICS INC's position in the market is strong, given its extensive portfolio and the critical nature of its work. However, the lack of recent contracts and specific agency clients raises questions about its current focus and future trajectory. Compared to industry peers, ELUSYS THERAPEUTICS INC is a dominant player in specialized areas, leveraging its expertise in medical countermeasures and advanced medical devices. The company's performance history and contract patterns suggest a stable and reliable partner for government agencies.

Specializations

• Pharmaceuticals
• Medical Devices
• Medical Countermeasures
• Advanced Medical Devices
• Public Health

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: moderate

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 60%

Competitive Position

ELUSYS THERAPEUTICS INC is a dominant player in specialized areas such as medical countermeasures and advanced medical devices. The company's extensive portfolio and critical nature of its work make it a preferred partner for government agencies. However, the lack of recent contracts and specific agency clients suggests a need for renewed focus on securing new business. ELUSYS THERAPEUTICS INC's strong performance history and competitive bidding approach indicate a solid market position, but there is room for growth and diversification.

Value to Taxpayers

ELUSYS THERAPEUTICS INC provides substantial value to taxpayers through its critical support in developing medical countermeasures and advanced medical devices. The company's average contract size of $124.27 million reflects the high value of the work it undertakes, which is essential for national security and public health. However, the lack of recent contracts and specific agency clients raises questions about the company's current focus and future trajectory, which could impact the efficiency and effectiveness of its operations.

Agency Relationships

ELUSYS THERAPEUTICS INC has a diversified client base, with no single agency accounting for a significant portion of the business. This suggests a balanced approach to client dependency, which is beneficial for risk management. However, the lack of specific agency clients and recent contracts raises questions about the company's current focus and future trajectory. The company's strong performance history and critical nature of its work make it a reliable partner for government agencies, but there is a need for renewed focus on securing new business.

Red Flags

• Lack of recent contracts and specific agency clients suggests a need for renewed focus on securing new business.
• No sole-source contracts indicate a preference for competitive bidding, which may limit the company's ability to secure large contracts.
• The lack of specific agency clients and recent contracts raises questions about the company's current focus and future trajectory.

Green Flags

• Extensive portfolio and critical nature of its work make ELUSYS THERAPEUTICS INC a preferred partner for government agencies.
• Strong performance history and competitive bidding approach indicate a solid market position.
• Diversified client base suggests a balanced approach to client dependency.

Key Contracts

ELUSYS THERAPEUTICS INC has undertaken several significant contracts, including the development of medical countermeasures and advanced medical devices. These projects have been crucial for national security and public health, demonstrating the company's capabilities and performance. For example, the company's work on medical countermeasures has helped to protect the nation from potential biological threats, while its development of advanced medical devices has improved patient care and outcomes. These contracts reveal the company's focus on critical areas and its ability to deliver high-value solutions. The company's track record of successful projects and strong performance history suggest a reliable and capable partner for government agencies. However, the lack of recent contracts and specific agency clients raises questions about the company's current focus and future trajectory.

Frequently Asked Questions

Recent Federal Contracts

Elusys Therapeutics Inc has 5 federal contracts on record. Below are the largest awards:

Related Pages